# Effect of CD07805/47 Gel in Rosacea Flushing

> **NCT02300129** · PHASE2 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 34 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** CD07805/47, CD07805/47+Placebo, Placebo, CD07805/47, Placebo
- **DRUG:** Placebo, CD07805/47+Placebo, CD07805/47, CD07805/47, Placebo
- **DRUG:** CD07805/47, CD07805/47+Placebo, Placebo, Placebo, CD07805/47
- **DRUG:** Placebo, CD07805/47+Placebo, CD07805/47, Placebo, CD07805/47

## Key facts

- **NCT ID:** NCT02300129
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02300129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02300129, "Effect of CD07805/47 Gel in Rosacea Flushing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02300129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*